Genome Institute at Washington University

Genome Institute at Washington University
Name	Genome Institute at Washington University
Established	1993
Location	St. Louis, Missouri
Parent	Washington University in St. Louis
Type	Research institute
Director	Eric D. Green

Genome Institute at Washington University

The Genome Institute at Washington University is a biomedical research institute affiliated with Washington University in St. Louis and located in St. Louis, Missouri. The institute is a focal point for large-scale genomics, collaborating with institutions such as the National Institutes of Health, the Broad Institute, the Wellcome Trust Sanger Institute, and the European Molecular Biology Laboratory. Its work intersects projects linked to the Human Genome Project, the 1000 Genomes Project, and initiatives supported by the National Human Genome Research Institute.

History

Founded during the era of the Human Genome Project and early genomics expansion, the institute grew from collaborations among faculty at Washington University School of Medicine, Genome Sequencing Center (Washington University), and investigators associated with the Institute for Genomic Research. Early leaders participated in sequencing efforts alongside figures from the Wellcome Trust and the Whitehead Institute. Over subsequent decades the institute contributed to population-scale studies related to the International HapMap Project, the ENCODE Project Consortium, and disease-focused consortia that included researchers from the Broad Institute and the Johns Hopkins University.

Mission and Research Focus

The institute’s mission centers on applying high-throughput sequencing to human health and disease, partnering with disease-focused centers such as the Alzheimer’s Disease Research Center (Washington University), the Siteman Cancer Center, and the McDonnell Genome Institute network. Research emphasizes genomic medicine, cancer genomics, infectious disease genomics, and rare disease diagnostics, linking projects to stakeholders like the Food and Drug Administration, the Centers for Disease Control and Prevention, and philanthropic funders including the Bill & Melinda Gates Foundation. Collaborations extend to specialty centers at Harvard University, University of Cambridge, Stanford University, and Yale University.

Facilities and Technology

Facilities include high-throughput sequencing cores equipped with platforms originally developed by companies related to the Illumina lineage and technologies influenced by inventors associated with Pacific Biosciences and Oxford Nanopore Technologies. The institute houses computational clusters interoperable with resources like the National Center for Biotechnology Information and cloud collaborations with Amazon Web Services and the Google Cloud Platform. Laboratory infrastructure supports sample processing workflows similar to those at the Sanger Institute and biobanking approaches compatible with standards from the National Cancer Institute and the Broad Institute.

Major Projects and Contributions

The institute contributed data and analyses to the Human Genome Project completion and subsequent population catalogs such as the 1000 Genomes Project and the Exome Aggregation Consortium (ExAC). It led or co-led disease-focused studies in cancer genomics consistent with panels organized by the Cancer Genome Atlas (TCGA) and partnered on infectious disease sequencing tied to outbreaks monitored by the Centers for Disease Control and Prevention and the World Health Organization. Other notable contributions include diagnostic pipelines for rare Mendelian disorders used by clinical centers like Mayo Clinic and Boston Children’s Hospital and collaborative studies with the Children’s Hospital of Philadelphia and the National Institutes of Health Clinical Center.

Organization and Leadership

The institute operates within the administrative framework of Washington University School of Medicine and reports to university leadership including the Chancellor of Washington University in St. Louis and the dean of the school of medicine. Directors and principal investigators have included faculty with appointments in departments such as Department of Genetics (Washington University School of Medicine), and collaborations extend to chairs and investigators from institutions like Massachusetts General Hospital, University of California, San Francisco, and Columbia University. Governance includes scientific advisory boards with members drawn from organizations including the National Academy of Sciences and grant panels convened by the National Institutes of Health.

Education and Training Programs

The institute supports graduate and postdoctoral training in coordination with the Washington University School of Medicine graduate programs, offering rotations and mentorship tied to curricula similar to programs at the Broad Institute and the Cold Spring Harbor Laboratory. Training includes workshops on sequencing technologies, bioinformatics internships modeled after programs at EMBL and the European Bioinformatics Institute, and clinical genomics fellowships coordinated with the American Board of Medical Genetics and Genomics pathways used by clinical genetics training programs at institutions such as Johns Hopkins University and Stanford University.

Funding and Partnerships

Funding sources include competitive grants from the National Institutes of Health, cooperative agreements with the Centers for Disease Control and Prevention, philanthropic awards from entities like the Gates Foundation and the Bill & Melinda Gates Foundation, and collaborative contracts with industry partners analogous to Illumina and cloud providers such as Amazon Web Services and Google Cloud. Strategic partnerships span academic consortia including the Broad Institute, the Wellcome Trust Sanger Institute, and university hospitals like Barnes-Jewish Hospital and St. Louis Children’s Hospital.

Category:Research institutes in the United States Category:Washington University in St. Louis